News
MédiS, a major player in the Tunisian pharmaceutical industry, announces the launch of the first biosimilar of Glargine insulin for diabetes treatment on February 18, 2022, following approval from the Ministry of Health.
In the realm of personal protective equipment, non-medical masks, also known as barrier masks or cloth masks, serve as individual protection for the general public and should not be used by healthcare professionals in direct contact with patients. (1, 4)
Telecommuting refers to working for an employer outside of the workplace. In exceptional circumstances, such as the coronavirus epidemic, this practice can be imposed on employees without their consent.
On March 2, 2015, MédiS obtained authorization to market the first human-origin recombinant alpha erythropoietin (EPO), marking a significant milestone in the Tunisian pharmaceutical industry.
MediS, dedicated to serving health, embodies our laboratory's philosophy. Over the years, we have consistently provided patients with high-quality medications while ensuring cost-effectiveness in managing their conditions, particularly pain.